Dipyridamole Inhibits Leukotriene B₄ Synthesis

• References

• 1 Gresele P, Zoja C, Deckmyn H, Arnout J, Vermylen J, Verstraete M. Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemostas 1983; 50: 852-856
• 2 Harker LA, Kadatz RA. Mechanism of action of dipyridamole. Thromb Res 1983; Suppl IV 39-46
• 3 Gresele P, Arnout J, Deckmyn H, Vermylen J. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity. Thromb Haemostas 1986; 55: 12-18
• 4 Gresele P, Arnout J, Coene MC, Deckmyn H, Vermylen J. Leukotriene B₄production by stimulated whole blood: comparative studies with isolated polymorphonuclear cells. Biochem Biophys Res Commun 1986; 137: 334-342
• 5 Morisaki N, Stitts JM, Bartels-Tomei L, Milo GE, Panganamala RR, Cornwell DG. Dipyridamole: an antioxidant that promotes the proliferation of aorta smooth muscle cells. Artery 1982; 11: 88-107
• 6 Deckmyn H, Gresele P, Arnout J, Todisco A, Vermylen J. Prolonging prostacyclin production by nafazatrom or dipyridamole. Lancet 1984; 2: 410-411
• 7 Cashman J. Leukotriene biosynthesis inhibitors. Pharmaceut Res 1985; 6: 253-261
• 8 Egan RW, Tischler AN, Baptista EM, Ham EA, Soderman DD, Gale PH. Specific inhibition and oxidative regulation of 5-lipoxygenase. Adv Prostagl Thrombox Leukotriene Res 1983; 11: 151-157
• 9 Schaub R, Yamashita A. Leukocyte mediated vascular injury and thrombosis is reduced by an inhibitor of 5-lipoxygenase: an in vivo study. Thromb Haemostas 1985; 54: 233 (Abstr)
• 10 Hermann KS. Lipoxygenase products: leukotrienes C₄, D₄, A₄’s breakdown products and 12-HPETE influence platelet aggregation in vivo. Prostaglandins 1985; 29: 459-465
• 11 Mehta P, Mehta J, Lawson D, Krop I, Letts LG. Leukotrienes potentiate the effects of epinephrine and thrombin on human platelet aggregation. Thromb Res 1986; 41: 731-738
• 12 Piper PJ. Formation and actions of leukotrienes. Physiol Rev 1984; 64: 744-761